Interesting to hear that $JNJ has provided $ARWR all 3 of its optional targets &amp; ARWR is performing preclinical work on each of them at present. It seems JNJ is very excited to expand its #RNAi portfolio and would expect JNJ is odds on favorite to be ARWR partner on #COVID19